The profitability of MURPHY USA INC. over the past 10 years
Chart MURPHY USA INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →MURPHY USA INC. reported net income of $470.6M in fiscal 2025, the latest fiscal year on file. That year it had operating income of $718.5M. It reported a profit in all 10 years shown. Its highest net income in these years was $672.9M, in fiscal 2022.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | — | $718.5M | $470.6M |
| 2024ended Dec 31, 2024 | — | $742.9M | $502.5M |
| 2023ended Dec 31, 2023 | — | $826M | $556.8M |
| 2022ended Dec 31, 2022 | — | $968.4M | $672.9M |
| 2021ended Dec 31, 2021 | — | $604M | $396.9M |
| 2020ended Dec 31, 2020 | — | $559M | $386.1M |
| 2019ended Dec 31, 2019 | — | $268.5M | $154.8M |
| 2018ended Dec 31, 2018 | — | $325.1M | $213.6M |
| 2017ended Dec 31, 2017 | $10.84B* | $283.3M | $245.3M |
| 2016ended Dec 31, 2016 | $9.62B* | $388.1M | $221.5M |
Fiscal years as MURPHY USA INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on MURPHY USA INC.
- The revenue of MURPHY USA INC.
- The cash flow of MURPHY USA INC.
- The debt of MURPHY USA INC.
- The dividends of MURPHY USA INC.
- All of MURPHY USA INC.'s financials, charted
Companies of a similar size
- BXPBXP, INC.
- RRXREGAL REXNORD CORP
- BIOBIO-RAD LABORATORIES, INC.
- PTGXProtagonist Therapeutics, Inc
- AYIACUITY INC
Not investment advice. This page shows what MURPHY USA INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.